The 1Florida ADRC is a consortium of Florida institutions — Mount Sinai Medical Center, UF, FAU, FIU and the University of Miami. Their team evaluates people with and without memory disorders and other thinking problems for diagnosis and participation in research studies. Under the supervision of the FDA, they test new medicines to research their effectiveness on Alzheimer’s disease.
The mission of the UFHCC is to prevent, detect, treat and ultimately cure cancer while addressing the unique challenges of the cancer burden faced by the population we serve.
The mission of the CTSI is to improve human health by accelerating the translation of scientific discoveries and the implementation of evidence-based best practices for the diagnosis, treatment, prevention and cure of human disease.
One of the main GRECC missions is to ensure that VA staff are prepared to work with older Veterans. The GRECCs provide training to VA staff, community health care providers, Veterans, and caregivers across many settings.
JAX-ASCENT was created to provide an integrative physical and intellectual environment in which trainees at all levels and scientists from diverse disciplines can interact and conduct clinical and behavioral translational research on aging and independence of older adults.
The MBI investigators hope to make a difference for those who suffer from disorders of the brain including neurodegenerative diseases, brain cancers, addictive and psychiatric diseases, stroke, acute spinal cord injuries and brain injuries as well as memory loss associated with normal aging.
The Resource Centers for Minority Aging Research (RCMAR) are designed (1) to enhance the diversity of the aging research workforce by mentoring promising scientists from under-represented groups for sustained careers in aging research in priority areas of social, behavioral, and economic research on aging.
At the BRRC, unique teams of scientists conduct research to improve the effectiveness of neurorehabilitation. They work to improve current treatments as well as to create treatment innovations that may restore impairments caused by neurological diseases and injuries such as stroke and incomplete spinal cord injury.